drug

(hyaluronidase (recombinant, human) + trastuzumab)

Marketedupdated 3mo ago

by Genentech Inc

Approved

community read0 votes

indications

investigational

Breast Cancer

all catalysts(0)

nothing on the calendar yet

Trials studying (hyaluronidase (recombinant, human) + trastuzumab)

phase1A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and Tolerability of Bmab3000 and Herceptin Hylecta® After a Single 600 mg SC Injection in Healthy Male Volunteersrecruitingn=150

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 49m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

(hyaluronidase (recombinant, human) + trastuzumab)

Marketedupdated 3mo ago

by Genentech Inc

Approved

community read0 votes

indications

investigational

Breast Cancer

all catalysts(0)

nothing on the calendar yet

Trials studying (hyaluronidase (recombinant, human) + trastuzumab)

phase1A Phase 1 Comparative Study to Evaluate Pharmacokinetics, Immunogenicity, Safety and Tolerability of Bmab3000 and Herceptin Hylecta® After a Single 600 mg SC Injection in Healthy Male Volunteersrecruitingn=150

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 49m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

(hyaluronidase (recombinant, human) + trastuzumab)

indications

all catalysts(0)

Trials studying (hyaluronidase (recombinant, human) + trastuzumab)

News(0)

Report a data issue

comments(0)

(hyaluronidase (recombinant, human) + trastuzumab)

indications

all catalysts(0)

Trials studying (hyaluronidase (recombinant, human) + trastuzumab)

News(0)

Report a data issue

comments(0)